Aldose reductase is a potential therapeutic target for neurodegeneration

Chem Biol Interact. 2024 Jan 5:110856. doi: 10.1016/j.cbi.2024.110856. Online ahead of print.ABSTRACTNeurodegeneration is a complex process involving various inflammatory mediators and cellular responses. Aldose reductase (AR) is a key enzyme in the polyol pathway, which converts glucose to sorbitol. Beyond its metabolic role, AR has also been found to play a significant role in modulating neuroinflammation. This review aims to provide an overview of the current knowledge regarding the involvement of AR inhibition in attenuating neuroinflammation and complications from diabetic neuropathies. Here, we review the literature regarding AR and neuropathy/neurodegeneration. We discuss the mechanisms underlying the influence of AR inhibitors on ocular inflammation, beta-amyloid-induced neurodegeneration, and optic nerve degeneration. Furthermore, potential therapeutic strategies targeting AR in neurodegeneration are explored. The understanding of AR's role in neurodegeneration may lead to the development of novel therapeutic interventions for other neuroinflammatory disorders.PMID:38185272 | DOI:10.1016/j.cbi.2024.110856
Source: Chemico-Biological Interactions - Category: Molecular Biology Authors: Source Type: research